Dedifferentiation of prostate smooth muscle cells in response to bacterial LPS

LEIMGRUBER, C.; QUINTAR, A. A.; SOSA, LV; GARCIA, L. N.; FIGUEREDO, M.; MALDONADO, C. A.

PROSTATE

WILEY-LISS, DIV JOHN WILEY & SONS INC

Año: 2011 vol. 71 p. 1097 - 1107

0270-4137

BACKGROUND: Prostate smooth muscle cells (SMCs) are strongly involved in the development and progression of benign prostatic hyperplasia and prostate cancer. However, their participation in prostatitis has not been completely elucidated. Thus, we aimed to characterize the response of normal SMC to bacterial lipopolysaccharide (LPS). METHODS: Primary prostate SMCs from normal rats were stimulated with LPS (0.1, 1, or 10 microg/ml) for 24 or 48 hr. The phenotype was evaluated by electron microscopy, immunofluorescence, and Western blot of SMCalpha-actin (ACTA2), calponin, vimentin, and tenascin-C, while the innate immune response was assessed by immunodetection of TLR4, CD14, and nuclear NF-kappaB. The secretion of TNFalpha and IL6 was determined using ELISA. RESULTS: Bacterial LPS induces SMCs to develop a secretory phenotype including dilated rough endoplasmic reticulum cisternae with well-developed Golgi complexes. Furthermore, SMCs displayed a decrease in ACTA2 and calponin, and an increase in vimentin levels after LPS challenge. The co-expression of ACTA2 and vimentin, together with the induction of tenascin-C expression indicate that a myofibroblastic-like phenotype was induced by the endotoxin. Moreover, LPS elicited a TLR4 increase, with a peak in NF-kappaB activation occurring after 10 min of treatment. Finally, LPS stimulated the secretion of IL6 and TNFalpha. CONCLUSIONS: Prostate SMCs are capable of responding to LPS in vitro by dedifferentiating from a contractile to a miofibroblastic-like phenotype and secreting cytokines, with the TLR4 signaling pathway being involved in this response. In this way, prostate SMCs may contribute to the pathophysiology of inflammatory diseases by modifying the epithelial-stromal interactions.